Summary. Reovirus type 2 that had been isolated from a cow with diarrhoea and passaged in bovine kidney cell culture produced a Type i (insulin-dependent) diabetes-like syndrome when inoculated into NC mice. The infection resulted in insulitis and destruction of islet cells. Viral antigens were found in islet cells by staining with fluorescein-labelled antibody to reovirus type 2. The destruction of islet cells resulted in abnormalities shown on glucose tolerance testing. Studies on the susceptibility of the host showed that only certain strains of mice had overtly abnormal glucose tolerance tests when infected with reovirus type 2. To assess the immunological role in the pathogenesis of reovirus type 2-induced diabetes, infected mice were subjected to immunosuppressive or thymic hormone treatment. The administration of either anti-thymocyte serum or serum thymic factor reduced or prevented the development of the diabetes-like syndrome, while Arg-Lys-Asp-Val-Try did not show any therapeutic effects.
A virus might cause some cases of Type i (insulin-dependent) diabetes mellitus by infecting and destroying pancreatic Beta cells [1] . Mumps, rubella and members of the coxsackievirus B group (particularly B4) have most frequently been suggested as possible causes of Type 1 diabetes [1] [2] [3] [4] [5] [6] . A coxsackievirus B4 variant, isolated from the pancreas of a 10-year-old child who died from diabetic ketoacidosis, produced diabetes in SJL mice by infecting and destroying Beta cells [7] .
We have previously shown that reovirus type i and 3, passaged in murine pancreatic Beta-cell cultures, produced an insulitis when the virus was inoculated into 1-2-day old mice [8, 9] . In the present experiments, reovirus type 2 (reo-2) was used to determine whether this virus was diabetogenic to mice, and whether reo-2-induced diabetes could be suppressed by immunosuppression or thymic hormone treatment. Histopathology, immunofluorescence and glucose tolerance tests were used to evaluate the diabetogenicity of the virus, and the effect of immunosuppression or hormone treatment against virus-induced diabetes was investigated.
Materials and methods

Animals and virus
Male and female 2-3-day old NC mice were infected i. p. with BN-77 strain of reo-2 [10] which had been isolated from a cow with diarrhoea and passaged 10 times in bovine kidney cells [11] . This virus was originally isolated in our institute. The infectious titre of reo-2 was determined by inoculating confluent HmLu-1 cell [10] monolayers (60 mm dishes) with 0.2 ml of appropriate dilutions of the virus sample. After adsorption for 1 h at 37~ the monolayers were covered with agarose medium [1% (weight/volume) agarose with Eagle's MEM and 5% fetal bovine serum]. Monolayers were subsequently stained on day 6 with 1:40,000 dilution of neutral red. Plaques were counted within 24 h, and the virus titre was expressed as plaque-forming units (pfu/ml).
Immunofluorescent antibody technique
Antibody to reo-2 was prepared by repeated i.p. inoculation on 6-week-old guinea pigs with 106 pfu of reo-2 as described previously [9, 11] . The 50% neutralization titre of the antiserum to reo-2 was 1:1000 [11] . The y-globulin fraction of the serum, purified by ammonium sulphate precipitation and DEAE cellulose column chromatography, was conjugated with fluorescein isothiocyanate (FITC) [12] . Unconjugated FITC was removed by gel filtration through Sephadex G-50. The labelled y-globulin was adsorbed with acetone-treated mouse liver powder to eliminate non-specific fluorescence. The specificity of the labelled antiserum was established by an inhibition test using unlabelled antiserum to reo-2. FITC-conjugated anti-reo-2 antisera did not react with paraffin pancreas sections from uninfected NC mice. Sections of pancreas were stained with labelled antiserum as described previously [6] .
Virus neutralization test
Neutralization titres were determined by incubation of 400 pfu of virus in a volume with twofold serial dilutions of serum for 1 h at 37~ A reduction in the number of plaques by 50% served as the end 
Analytical methods
Blood glucose levels and glucose tolerance tests were performed in two groups of animals (6-10 mice per group) as described previously [13] . Measurements of blood glucose levels of non-fasted animals and 60-min glucose tolerance tests (GTTs) on non-fasted animals were performed on post-infectious days 5, 7,10, 14 and 17. The mean non-fasting glucose level of 50 uninfected animals was 8.2_+ 1.2 mmol/1. In these experiments, any infected mouse with a nonfasting glucose level greater than 11.9 mmol/1 (3 SD above the mean) was denoted as diabetic.
The mean glucose level of GTTs in 50 uninfected animals was 9.0 + 0.9 mmol/1. Any infected mouse with a glucose level greater than 11.7 mmol/1 (3 SD above the mean) was denoted as diabetic.
Serum immunoreactive insulin (IRI) was measured by enzymelinked immunosorbent assay procedure with porcine insulin used as the standard (Glazyme, Wako, Osaka, Japan).
Immunosuppression and hormone treatments
Rabbit anti-mouse thymocyte serum (ATS) (Ceder Lane, Ontario, Canada), with cytotoxic titre 1:1,600 was used as the immunosuppressive agent. ATS did not show the neutralizing activity against reo-2 and did not react with reo-2-infected HmLu-1 cell monolayers by indirect immunofluorescence. ATS or normal rabbit serum treatment consisted of three 0.tmt i.p. injections on post-infection days 0, 4 and 7. Synthetic serum thymic factor (FTS, H-pyr(Glu)-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH) and Arg-Lys-Asp-Val-Try (TP-5) (Mitsui Pharmaceutical Co., Tokyo, Japan) in phosphate buffered saline (PBS, 0.14 mol/1 NaC1, 2.Tmmol/1 KC1, 8.0mmol/1 Na~_HPO4, 1.5 mmol/1 KH2PO4) were injected i.p. in the mice on post-infection day 14.
Statistical analysis
Statistical significance of the differences between the mean of the sample groups was tested by Student's t-test with the Welch's adjustment for unequal variances where necessary [1@ The significance difference of p < 0.01 was used as a measure of statistical significance.
Results
Virus-induced metabolic alterations
To examine whether the severity of the diabetes was dependent upon the dose of the virus, animals were inoculated with 104-107 pfu of virus. Non-fasting blood glucose levels decreased on post-infection day 5 (2.8-5.3 mmol/1 in 50% of mice). Glucose levels then recovered to normal levels, but never became overtly hyperglycaemic. Approximately 20% of NC mice inoculated with 104 pfu of virus developed diabetes using GTTs on post-infection days 14. This increased to 80% when mice were inoculated with 105 pfu of virus. No further increase was observed when animals were inoculated with 106 or 107 pfu of virus.
The duration of the abnormal GTTs induced by reo-2 in NC mice is illustrated in Figure 1 A. On day 14 after inoculation, the mean abnormal GTT was 24.2 mmol/1 and 80% of animals manifested abnormalities. Abnormal GTTs were still apparent in some animals on post-infection day 21 .
To see whether the abnormal GTI's were attributable to abnormal insulin levels, the amount of insulin in the plasma was determined at different time intervals after infection. The amount of insulin in the plasma of the infected mice with abnormal GTTs was lower than that of uninfected mice determined at each time interval (Table 1) . Plasma insulin levels of the infected mice with normal GTTs were not statistically different from those of the uninfected mice. 
Destruction of pancreatic islet cells and demonstration of viral antigens in NC mice
To determine if abnormal GTFs were secondary responses to reo-2-induced islet cell damage, sections of pancreas from infected and uninfected mice were examined microscopically. Islets from animals infected with reo-2 revealed infiltration of neutrophiles and mononuclear cells in 80% of the islets of Langerhans (Fig. 2 A, B) . Though no distinct change was seen within 7 days of infection, mild inflammatory changes were seen on post-infection day 10, and the inflammation was maximal on day 14. The severity of the inflammatory changes varied considerably among animals and within the pancreas with some islets showing little change while others showed moderate to extensive cell infiltration. In some areas of the pancreas, only a portion of the islet was involved. In the most severely affected areas, islet cell destruction and coagulation necrosis were observed. No acinar cell damage was observed. Atrophic islets were occasionally seen on post-infection day 21 .
To confirm that the virus was actually replicating in pancreatic Beta cells, sections from the pancreas of reo-2 infected mice were stained with FITC-labelled antibody responsive to reovirus (Fig.3) . On post-infection day 5, viral antigens were seen in the cytoplasm of islet cells and occasionally in the cytoplasm of acinar cells. Maximal viral antigen distribution was observed on post-infection day 7. Haematoxylin and eosin staining revealed mild degenerative changes in the islets with viral antigens. However, viral antigens were difficult to detect in the subsequent 10 days. The degree of islet cell involvement varied considerably; some islets indicated only a few cells, whereas others manifested almost all cells containing the viral antigens. Occasionally viral antigens were observed in acinar and ductal cells.
From the pancreas, 102-103 and 104-106 pfu of the virus per organ were recovered on post-infection days 3 and 5, respectively. These isolated stocks of virus were completely neutralized with anti-reo-2 guinea pig serum.
Mouse strain differences on the development of diabetes
To see whether the induction of diabetes by reo-2 was influenced by the host, 2-3-day old BALB/c and CD-1 mice were infected and GTTs were performed. Not less than 10NC mice in each group were infected with 1 x 105 pfu of reovirus type 2 and treated with FTS two weeks later. Glucose tolerance testing was performed on post-infection day 17. Statistically significant (p < 0.01) differences in blood glucose levels were obtained between the 10 gg FTS-treated virus-infected and the FTS non-treated virus-infected groups; and the 1 gg FFS-treated virus-infected and FTS non-treated virus-infected groups, b Values for blood glucose are expressed as mean _+ SD Table   3 . Effects of anti-thymocyte serum (ATS) to reovirus type 2-induced diabetes meltitus a Not less than 10NC mice in each group were infected with I x 10 s pfu of reovirus type 2 and treated three times with ATS in two weeks. Glucose tolerance testing was performed on post-infection day 17. Statistically significant (p < 0.01) differences in blood glucose levels were obtained between ATS-treated virus-infected and ATS non-treated virus-infected groups, u Values for blood glucose are expressed as mean _+ SD Table 4 . Effect of TP-5 to reovirus type 2-induced diabetes mellitus a 
Suppression of diabetes by serum thymic factor and anti-thymocyte serum
As shown in Table 2 , NC mice that had been infected with reo-2 recovered from diabetes when treated i. p. with synthetic FTS at a dose of 10 or 1 Bg. Recovery was similarly 195 observed when FTS was injected on post-infection day 14, when the animals began to show symptoms of diabetes. However, mice treated with 0.1 or 0.01 btg FTS did not recover from the induced diabetes. ATS was tested for its effect on the development of reo-2-induced diabetes. As shown in Table 3 , reo-2 produced abnormal GriTs in NC mice, but these abnormalities were reduced or prevented by the treatment with ATS. Reo-2-infected mice injected with normal rabbit sera and TP-5 (10, 1 or 0.1 btg doses) did not recover from the diabetes induced (Table 4) .
Discussion
Our present experiments show that reo-2 can infect and damage pancreatic islet cells in certain inbred strains of mice followed by the appearance of virus antigen in pancreatic islets and abnormal GTTs. Thus, destruction of Beta cells by the virus appeared to be responsible for the abnormal results seen in GTTs. As for EMC virus and coxsackievirus [1, 5] , the degree of islet cell damage produced by reo-2 varies considerably among animals, even though inbred strains of mice of the same age and sex were used. This variation in Beta cells is probably responsible for the observed differences in the metabolic response of individual animals. In most of the animals, abnormal GTTs were transient. This may be due to the fact that a sufficient number of Beta cells are left intact after the infection, and proliferation of these cells results in metabolic compensation.
In the present experiments, immunosuppression with ATS greatly reduced the degree of insulitis and islet cell damage. By determination of virus growth in vivo, it is possible to evaluate that ATS prevented diabetes development by inhibiting virus replication (such as by antiviral antibody in the immunosuppressive sera or induction of interferon), rather than by suppressing the inflammation response. Virus titres in homogenates of liver, heart and pancreas were approximately the same in ATStreated and non-treated mice on post-infection days 3, 5, 10 and 14. Virus isolations were negative in these organs on days 10 and 14 (data not shown). These results suggest that ATS does not inhibit virus replications. Reovirus Type 1 can cause immunopathological damage to pancreatic Beta cells [9, 16] . Our results with reo-2 infection and immunosuppression indicate that immunological damage might be relevant to reo-2-induced diabetes.
Abnormal GTTs were also prevented by a single injection of FTS on post-infection day 14. Virus isolations on days 14 and 17 were negative in the liver, heart and pancreas of either hormone-treated or non-treated mice. This hormone has been reported to elicit many interesting immunological effects, such as in vitro and in vivo promotion of differentiation of precursor T cells to mature T cells (theta conversion), enhanced generation of alloantigen reactive cytotoxic T cells in thymectomized mice, induction of suppressor T cells in NZB mice, prolongation of murine skin grafts, and suppression of experimental allergic encephalomyelitis (EAE) induced in guinea pigs [17] [18] [19] [20] . Guinea pigs that suffer severe paralysis with distinct incontinence from EAE recover on FTS treatment [17] . Of these immunoregulatory effects of FTS, induction of suppressor T cells is particularly interesting because it suggests that the remarkable effect of FTS that we observed is probably due to induction of suppressor T cells. We are now investigating this possibility.
Previous reports have shown T cell abnormalities or imbalance, and suppressor T cell decrease in the peripheral blood of Type i diabetic patients [21, 22] . FTS with the same chemical structure has been thought to exist in many animals and in humans [23] . From these previous studies on patients with Type 1 diabetes, FTS might be useful as a therapeutic agent for these cases. Metabolic alterations caused by murine pancreatic Beta-cell infection with reo-2 (our present experiment) and reovirus Type i and 3 [8, 9] reveal the extensively disseminated viruses in human are capable of inducing a diabetes-like syndrome in mice. However, whether these viruses actually play a role in the aetiology of Type I diabetes is still not known.
